Back to results
US 12,747,278 B2Granted
Chimeric antigen receptor for treatment of cancer
AssigneesSmt Bio Co., Ltd., Industry-Academic Cooperation Foundation, Yonsei University
InventorsYong Yoon Chung, In Hye Jung
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel chimeric antigen receptor and to a pharmaceutical composition for preventing or treating containing the same.
Claims1
A method for treating cancer in a subject, comprising intravenously administering to the subject a population of T cells expressing a chimeric antigen receptor targeting carcinoembryonic antigen (CEA),
- wherein the chimeric antigen receptor comprises a polypeptide having the amino acid sequence of SEQ ID NO:
- 9 or 10,
- wherein the cancer is CEA-expressing pancreatic cancer.
Dependencies are inferred from the claim text.